1st Counsel – Lifestyle
Author:
CDT Equity Inc.
CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery
April 16, 2026
CDT Notes Sarborg Publication of PRISM Framework Expanding AI
April 7, 2026
CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings
March 26, 2026
CDT Equity Inc. Announces Reverse Stock Split
March 25, 2026
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
March 23, 2026
CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth
March 18, 2026
CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence
March 12, 2026
CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent
March 5, 2026